USMD ETF — Holdings & Analysis
The CoreValues America First Technology ETF (the Fund) seeks long-term capital appreciation. 0.87% expense ratio, inception 2025.
CoreValues America First Technology ETF (USMD) ETF — Price, Holdings & Analysis
ETF Genel Bakış
Risk Metrikleri
Gider Oranı
Temettü Verimi
- Invesco QQQ Trust, Series 1 (QQQ) — 0.18% expense ratio
- State Street Technology Select Sector SPDR ETF (XLK) — 0.08% expense ratio
- State Street Energy Select Sector SPDR ETF (XLE) — 0.08% expense ratio
- State Street SPDR Dow Jones Industrial Average ETF Trust (DIA) — 0.16% expense ratio
- iShares Russell 2000 ETF (IWM) — 0.19% expense ratio
- State Street Financial Select Sector SPDR ETF (XLF) — 0.08% expense ratio
- iShares MSCI Emerging Markets ETF (EEM) — 0.72% expense ratio
- State Street SPDR S&P 500 ETF (SPY) — 0.09% expense ratio
Risk Metrikleri
- Beta: 0.00
Sorular & Cevaplar
What is CoreValues America First Technology ETF (USMD)?
The CoreValues America First Technology ETF (the Fund) seeks long-term capital appreciation.
What is the expense ratio for USMD?
CoreValues America First Technology ETF has an expense ratio of 0.87%, which is considered higher than average for equity ETFs. This means for every $10,000 invested, annual fees would be approximately $87.
Lower expense ratios generally lead to better long-term returns, all else being equal.
How long has USMD been around?
CoreValues America First Technology ETF was launched in 2025, making it 1 years old. It is a relatively newer fund with a shorter track record.
What is the current NAV of USMD?
CoreValues America First Technology ETF has a net asset value (NAV) of approximately $24.50 per share. The NAV represents the per-share value of the fund's underlying assets minus liabilities.
Market price may differ slightly from NAV due to supply and demand dynamics during trading hours.
Is USMD a good investment?
CoreValues America First Technology ETF is a equity ETF. Equity ETFs are subject to market risk and can experience significant short-term volatility, though they have historically provided strong long-term returns for patient investors.
Whether it is suitable depends on your investment goals, risk tolerance, and time horizon. Consider consulting a financial advisor for personalized guidance.